Posted by Brad Weeks, MD on December 19, 2009
Dr. Weeks’ Comment: I first used topical, intradermal honey bee venom for immune enhancement in cancer patients 18 years ago.
Mellitin, the bee venom component now being developed as an anti-cancer drug, has many impressive qualities: anti-inflammatory, anti-cancer, immune stimulant.
Now the scientists at Washington University School of medicine at St Louis have been impressed by BVT and off we go!
20 years ago, when I was working with Charlie Mraz, master apitherapist and dear friend and mentor to me, we saw melanomas disappear after aggressive topical application of BVT (Bee Venom Therapy). Clinicially it was impressive but although we reported these results, until a natural product can be modified and patented and thereby rendered profitable, no one takes notice.
Remember the story of aspirin? Aspirin was developed by extracting the “active ingredient” from willow bark and the Bayer company made a fortune. People died in droves, however, because when the active ingredient, salicylic acid, was extracted and given as a drug, the lack of the protective agents (left behind in the discarded willow bark residue) caused ulcers. Oops… So Bufferin (aspirin plus the natural buffering agents) was created. Today, many of us simply recommend making a willow back tea or chewing the willow bark. Less death and other nasty side-effects.
Returning to the honey bee: Whole bee venom, offered by the bee via her natural delivery system (no preservatives required) also has its place but, being free of charge, no one talks about it.
Soon, however, for a pretty penny, you too can receive the benefits of bee venom therapy via a patented drug version. Or you can start keeping bees yourself: as have 43 of my patients thus far over the past 20 years!